Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1633 |
β-Amyloid (18-28)
β-Amyloid 18-28 |
||
Intracerebroventricular administration of synthetic peptides Beta-amyloid (12-20), (12-28), and (18-28) causes amnesia in mice. These peptides have only amino acid residues VFF at position 18 to 20 in common, suggesting the amnestic effect of the triad. | |||
TP1719 |
β-Amyloid (33-40)
β-Amyloid 33-40 |
||
β-Amyloid (33-40) is a peptide consisting of amino acid of 33 to 40 of beta amyloid protein. | |||
TP1500 |
β-Amyloid (1-17)
β-Amyloid 1-17 |
||
This synthetic peptide consists of amino acids 1 to 17 of beta amyloid protein. This peptide can be employed in beta amyloid solubility studies. | |||
TP1673 |
β-Amyloid (11-22)
β-Amyloid 11-22 |
||
β-Amyloid (11-22) is a peptide fragment of β-Amyloid.Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’s patients, is thought to be the cause of Alzheimer’s Disease (AD). AD is the most common neurodegenerat |